Ganuza Miguel, Hadland Brandon, Chabot Ashley, Li Chen, Kang Guolian, Bernstein Irwin, McKinney-Freeman Shannon
Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.
Exp Hematol. 2017 Jul;51:25-35.e6. doi: 10.1016/j.exphem.2017.04.006. Epub 2017 Apr 24.
Hematopoietic stem and progenitor cells (HSPCs) sustain life-long hematopoiesis and are first detected in the embryo by transplantation at embryonic day 10.5 (E10.5). HSPCs are mesodermal in origin and ultimately emerge from a subset of arterial endothelium (i.e., hemogenic endothelium [HE]), which is highly concentrated in the aorta-gonad-mesonephros region of the midgestation embryo. Here, we used clonal ex vivo assays, in which endothelial cells isolated from the midgestation aorta and vitelline and umbilical arteries are co-cultured on supportive stroma, to show that only about 0.1%, 1.3%, and 0.29% of E9.5, E10.5, and E11.5 endothelium are functional HE, respectively. We further show high phenotypic and functional variability in the hematopoietic potential of individual hemogenic endothelial precursors. Using unique niche stroma capable of providing the signals necessary for definitive hematopoietic stem cell (dHSC) induction, we demonstrate that this variability in HE includes their potential to support phenotypic dHSCs. These data suggest the presence of a continuum of maturing HE with distinct hematopoietic potential or HE representative of a heterogeneous pool of precursors that give rise to HSPCs with disparate hematopoietic potential.
造血干细胞和祖细胞(HSPCs)维持终生造血,在胚胎期第10.5天(E10.5)通过移植首次在胚胎中被检测到。HSPCs起源于中胚层,最终源自动脉内皮的一个子集(即造血内皮[HE]),其高度集中在妊娠中期胚胎的主动脉-性腺-中肾区域。在这里,我们使用克隆体外试验,即将从妊娠中期主动脉、卵黄动脉和脐动脉分离的内皮细胞在支持性基质上共培养,结果显示E9.5、E10.5和E11.5内皮中分别只有约0.1%、1.3%和0.29%是功能性HE。我们进一步表明,单个造血内皮前体的造血潜能存在高度的表型和功能变异性。利用能够提供确定造血干细胞(dHSC)诱导所需信号的独特小生境基质,我们证明这种HE的变异性包括它们支持表型dHSCs的潜能。这些数据表明存在具有不同造血潜能的成熟HE连续体,或者HE代表了一个异质的前体库,这些前体产生具有不同造血潜能的HSPCs。